Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Jonas B. Sandbrink"'
Autor:
Gene D. Godbold, F. Curtis Hewitt, Anthony D. Kappell, Matthew B. Scholz, Stacy L. Agar, Todd J. Treangen, Krista L. Ternus, Jonas B. Sandbrink, Gregory D. Koblentz
Publikováno v:
Frontiers in Bioengineering and Biotechnology, Vol 11 (2023)
Regulation of research on microbes that cause disease in humans has historically been focused on taxonomic lists of ‘bad bugs’. However, given our increased knowledge of these pathogens through inexpensive genome sequencing, 5 decades of research
Externí odkaz:
https://doaj.org/article/8cde06eb4d7146ef84f939180732ecf0
Autor:
George Altman, Janvi Ahuja, Joshua Teperowski Monrad, Gurpreet Dhaliwal, Charlie Rogers-Smith, Gavin Leech, Benedict Snodin, Jonas B. Sandbrink, Lukas Finnveden, Alexander John Norman, Sebastian B. Oehm, Julia Fabienne Sandkühler, Jan Kulveit, Seth Flaxman, Yarin Gal, Swapnil Mishra, Samir Bhatt, Mrinank Sharma, Sören Mindermann, Jan Markus Brauner
Publikováno v:
Scientific Data, Vol 9, Iss 1, Pp 1-9 (2022)
Measurement(s) Government non-pharmaceutical interventions against Covid-19 Technology Type(s) Interpretation by researchers Sample Characteristic - Organism Homo sapiens
Externí odkaz:
https://doaj.org/article/e7457c94cd48441e991a1004b0534dd1
Autor:
Mrinank Sharma, Sören Mindermann, Charlie Rogers-Smith, Gavin Leech, Benedict Snodin, Janvi Ahuja, Jonas B. Sandbrink, Joshua Teperowski Monrad, George Altman, Gurpreet Dhaliwal, Lukas Finnveden, Alexander John Norman, Sebastian B. Oehm, Julia Fabienne Sandkühler, Laurence Aitchison, Tomáš Gavenčiak, Thomas Mellan, Jan Kulveit, Leonid Chindelevitch, Seth Flaxman, Yarin Gal, Swapnil Mishra, Samir Bhatt, Jan Markus Brauner
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-13 (2021)
European governments control resurging waves of COVID-19 using nonpharmaceutical interventions. Here, the authors estimate the effectiveness of 17 interventions in Europe’s second wave, and analyse differences to the first wave as well as implicati
Externí odkaz:
https://doaj.org/article/183987d2bc5349c891601860f62e5575
Publikováno v:
npj Vaccines, Vol 6, Iss 1, Pp 1-7 (2021)
Abstract The ongoing COVID-19 pandemic has demonstrated the importance of rapid and versatile development of emergency medical countermeasures such as vaccines. We discuss the role of platform vaccines and prototype pathogen research in modern vaccin
Externí odkaz:
https://doaj.org/article/df88bc29ccc040d38772b3cc31cb2b72
Autor:
James Andrew Smith, Jonas B. Sandbrink
Publikováno v:
PLoS Biology, Vol 20, Iss 4 (2022)
The risk of accidental or deliberate misuse of biological research is increasing as biotechnology advances. As open science becomes widespread, we must consider its impact on those risks and develop solutions that ensure security while facilitating s
Externí odkaz:
https://doaj.org/article/a7bc5eae41734715a85a5c1c33a838e1
Autor:
Sriharshita Musunuri, Jonas B. Sandbrink, Joshua Teperowski Monrad, Megan J. Palmer, Gregory D. Koblentz
Publikováno v:
mBio, Vol 12, Iss 5 (2021)
The COVID-19 pandemic has demonstrated the world’s vulnerability to biological catastrophe and elicited unprecedented scientific efforts. Some of this work and its derivatives, however, present dual-use risks (i.e., potential harm from misapplicati
Externí odkaz:
https://doaj.org/article/950081839243431a9c4555d8bf8cefd4
Autor:
Jonas B. Sandbrink, Robin J. Shattock
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
The COVID-19 pandemic demonstrates the ongoing threat of pandemics caused by novel, previously unrecognized, or mutated pathogens with high transmissibility. Currently, vaccine development is too slow for vaccines to be used in the control of emergin
Externí odkaz:
https://doaj.org/article/756bf93d61a54b1ab6d3bf5adb7524e7
Autor:
Nadia X. Montazeri, Jonas B. Sandbrink
Publikováno v:
Health Security.
Publikováno v:
Gene Therapy. 30:407-410
Optimizing viral vectors and their properties will be important for improving the effectiveness and safety of clinical gene therapy. However, such research may generate dual-use insights relevant to the enhancement of pandemic pathogens. In particula
Autor:
Gavin Leech, Charlie Rogers-Smith, Joshua Teperowski Monrad, Jonas B. Sandbrink, Benedict Snodin, Robert Zinkov, Benjamin Rader, John S. Brownstein, Yarin Gal, Samir Bhatt, Mrinank Sharma, Sören Mindermann, Jan M. Brauner, Laurence Aitchison
Publikováno v:
Leech, G, Rogers-Smith, C, Monrad, J T, Sandbrink, J B, Snodin, B, Zinkov, R, Rader, B, Brownstein, J S, Gal, Y, Bhatt, S, Sharma, M, Mindermann, S, Brauner, J M & Aitchison, L 2022, ' Mask wearing in community settings reduces SARS-CoV-2 transmission ', Proceedings of the National Academy of Sciences of the United States of America, vol. 119, no. 23, e2119266119 . https://doi.org/10.1073/pnas.2119266119
Leech, G, Rogers-Smith, C, Monrad, J T, Sandbrink, J B, Snodin, B, Zinkov, R, Rader, B, Brownstein, J S, Gal, Y, Bhatt, S, Sharma, M, Mindermann, S, Brauner, J M & Aitchison, L 2022, ' Mask wearing in community settings reduces SARS-CoV-2 transmission ', Proceedings of the National Academy of Sciences, vol. 119, no. 23, e2119266119 . https://doi.org/10.1073/pnas.2119266119
Leech, G, Rogers-Smith, C, Monrad, J T, Sandbrink, J B, Snodin, B, Zinkov, R, Rader, B, Brownstein, J S, Gal, Y, Bhatt, S, Sharma, M, Mindermann, S, Brauner, J M & Aitchison, L 2022, ' Mask wearing in community settings reduces SARS-CoV-2 transmission ', Proceedings of the National Academy of Sciences, vol. 119, no. 23, e2119266119 . https://doi.org/10.1073/pnas.2119266119
The effectiveness of mask wearing at controlling severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission has been unclear. While masks are known to substantially reduce disease transmission in healthcare settings [D. K. Chu et al.,